View Profile

Jesús Novalbos Reina

Servicio de Farmacología Clínica · Fundación para la Investigación Biomédica del Hospital Universitario de La Princesa

https://researchid.co/jnovalbos
@iis-princesa.org
58Scopus Publications

Research Interests

Farmacogenetic, Drug Clinical Trials, Bioequivalence

Biography

Senior Researcher, Fundación de Investigación del Hospital de la Princesa in Madrid, since June. My role is to support research projects and provide technical and scientific advice in other functions of the Clinical Pharmacology Service, such as: expert reports on drugs, bioequivalences ... Previous experience: In the 12 years working in the pharmaceutical industry, I have held various positions, from head of research and development of generic drugs, different positions in medical and training departments, to being the head of a business unit, reporting directly from the departments of marketing, sales, and medical, and with reporting international projection.

Education

Degree in Biology Science 1996, Masters in Clinical Trial Monitoring 2000, Doctor of Medicine -pHd (area of Pharmacology) 2003, and Master in Fertility and Embryology.

Recent Scopus Publications

  1. Genomic and Sex Contributions to Interindividual Variability in Pitavastatin Bioavailability
    Basic and Clinical Pharmacology and Toxicology, 2026
  2. An Overview of Endometriosis and Potential Pharmacogenetic Targets
    Pharmaceutical Research, 2026
  3. Impact of CYP and ABCB1 Polymorphisms on Bortezomib-Induced Adverse Events in Multiple Myeloma
    Biomedicines, 2026
  4. Corrigendum to:“Apixaban kinetics could be influenced by sex, cytochrome P450 enzymes and SLC6A2 transporter”(Biomedicine & Pharmacotherapy, (2025), 193, C, (118732), (S0753332225009266), 10.1016/j.biopha.2025.118732)
    Biomedicine and Pharmacotherapy, 2025
  5. Apixaban kinetics could be influenced by sex, cytochrome P450 enzymes and SLC6A2 transporter
    Biomedicine and Pharmacotherapy, 2025

Links